Taraxasterol acetate targets RNF31 to inhibit RNF31/p53 axis-driven cell proliferation in colorectal cancer

Colorectal cancer (CRC) is the third most common cancer worldwide. Several studies have suggested that taraxasterol acetate (TA) can inhibit the growth of tumor cells. However, to date, it remains unclear how TA inhibits cell growth and how RNF31 functions as an oncogene. We examined the expression...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Chao-Tao, Yang, Jing, Liu, Zi-De, Chen, Youxiang, Zeng, Chunyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024285/
https://www.ncbi.nlm.nih.gov/pubmed/33824292
http://dx.doi.org/10.1038/s41420-021-00449-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024285/
https://www.ncbi.nlm.nih.gov/pubmed/33824292
http://dx.doi.org/10.1038/s41420-021-00449-5

Ejemplares similares